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ABSTRACT
Objective: This study determines the prevalence of metabolic syndrome (MS), with special reference to hyperglycemia and hyperlipidemia within 
urban population of a tertiary health-care hospital in Indore, Madhya Pradesh, India.
Methods: This cross-sectional study involved 726 subjects (467 men and 259 women). MS was defined using revised National Cholesterol Education 
Program (NCEP) criteria.
Results: When compared with the modified NCEP criteria, the prevalence of MS was found to be 7.51% (5.99% in men and 8.11% in women). 
Descriptive analysis exemplified a significantly increased mean values of fasting blood glucose (p<0.01), postprandial blood glucose (p<0.01), and 
lipid values (p<0.05) in the population. However, as compared to man, women showed significant elevated total cholesterol (p<0.05) and high-density 
lipoprotein (p<0.01). On the other hand, man exhibited increased triglycerides (p<0.05), cardiac risk ratio [C/H (p<0.01), and L/H (p<0.01)] than 
women. The highest prevalence of MS was seen in men of age group of 55-75 years and in women of age group of 20-34 years.
Conclusion: Our test population showed an increased rate of hyperglycemia and hyperlipidemia, with an increase in age, indicating a need to 
implement policies to control this abnormal MS.
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INTRODUCTION
Metabolic syndrome (MS) is a complex web of abnormally altered 
metabolic factors that are associated with two-five times increased the 
risk of developing diabetes and/or cardiac problems [1,2]. A number 
of studies showed that the abnormal and uncontrolled serum glucose 
and lipid levels are important and amenable risk factors which have 
become major causes of morbidity and mortality in the world [3-5]. 
According to the World Health Organization, dyslipidemia is associated 
with 50% ischemic heart disease and more than 4 million deaths 
per year in the world [6]. In a parallel way, in Asian countries also a 
steady increase in these metabolic factors has been reported [6,7]. 
Although the mechanism of development and progression of MS is very 
complex, the possible main reasons of progressing MS appear to be 
changing lifestyle, increasing consumption of fat-rich diet, sedentary 
lifestyle, mental stress, aging and other environmental factors 
that play a central role in altered metabolism, insulin insensitivity, 
obesity, atherosclerosis, etc. [1,8] and leads to the disturbed normal 
physiochemical processes [4,9,10].
Indeed, India already has 50 million diabetic patients [11], and the 
incidences of adult cardiac problems have also been increased to 8-10% 
in urban areas [12]. This is partly elucidated by their diabetes-susceptible 
genetic factors [1,9]. However, genetic factor alone cannot explain the rapid 
boost in these disorders. Certainly above-mentioned factors also play a 
significant role and their cumulative effects negatively influence the normal 
metabolism [4,10]. Although with especial reference to blood glucose and 
different lipid parameters several studies have been conducted, which 
helped to extract out comparative epidemiological data of different Indian 
populations [5,7,13,14], these are contradictory to each other. For example 
in National Urban Diabetes Study study, the prevalence of diabetes was 
found to be higher in south Indian cities than northern cities [15].
Some more reports of blood glucose and lipid profiles of population 
from different eastern, western, northern and southern India showed 
the growing incidences of irregularities in serum glucose and total 
cholesterol (TCHO), high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), and cardiac risk ratio (CRR) as well [4,13,16,17]. 
Some data were also documented in different age, sex, and diet groups 
of Indian populations [4,18,19]. However, the prevalence of these 
metabolic abnormalities and their sex and age specific distinction 
in a region of central India has not been studied till now. Because 
extensively different prevalence rates have been observed with the 
same parameters in different regions of India, much more studies 
are needed in different subtypes of populations so that overall health 
status, as well as risk factors, can be quantified. With these concepts, 
this study was aimed to evaluate the prevalence of metabolic disorders 
with special reference to blood glucose and lipid profile parameters of 
sample population of Indore.
METHODS
The study population consisted of subjects who had attended 
the general health checkup program at executive health scheme 
department, Bombay hospital, Indore, India, totaling 726 subjects of 
both sex (467 men and 259 women). Individuals of both sexes were 
further classified into three different age groups. Groups 1, 2 and 3 
have subjects of age 20-39, 40-54 and 55-80 years, respectively. In the 
health checkup department, patient’s physical and medical history was 
taken, and a copy of each report was maintained in the medical records 
department. The medical record folders of all these subjects were 
screened manually.
Here, only blood glucose and lipid profile data have been analyzed. All 
the subjects were fasted overnight and the blood samples collected 
in plain vacutainer tubes. All the tests were done using an automated 
analyzer (Xp and analyzer) based on Beer-Lambert’s law. Fasting blood 
glucose (FBS), postprandial blood glucose (PPBS), TCHO, HDL, and 
triglycerides (TGL) were estimated directly by autoanalyzer. While, 
LDL, very LDL (VLDL), C/H and L/H ratios were calculated out using 
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standard formulas [20,21]. Before analysis, the analyzer was calibrated 
with calibrators provided by the manufacturer. Controls were run at 
both normal and pathological concentrations for each analyte. During 
the course of the study, there was no change in the equipment, reagents, 
calibration standards, and controls.
The overall analysis was done at two stages. (1) The data were 
compared with normal reference values of National Cholesterol 
Education Program (NCEP) to determine the number and percentage 
of population falling in normal, borderline and diseased/risk range of 
these metabolic factors, which could give superficial idea about general 
health status of population, (2) descriptive and relative statistical 
analyses were carried out in whole, male and female individuals, which 
helped to provide a detailed report about the sample population. The 
data are expressed as the means±standard error (SE). Differences 
in mean values were compared using Prism Software, Version 5.1 
for Windows, Inc., La Jolla, CA, USA by one-way analysis of variance 
(ANOVA) followed by Student’s t-test. The p<0.05 was considered as 
statistically significant.
RESULTS
The incidence of MS was observed to be 7.51% (5.99% men and 
8.11% women) than NCEP criteria (Tables 1 and 2). For values of 
FBS and PPBS, 5.11% and 13.92% individuals showed borderline 
hyperglycemia, while 18.92% and 17.47% individuals were found 
to be hyperglycemic, respectively. In the case of TCHO, LDL, HDL 
and TGL also, only 66.52%, 36.91%, 81.63% and 68.32% population 
exhibited normal range; while a considerably decreased number of 
people showed normal values of C/H and L/H (28.73% and 13.39%, 
respectively). Although no significant difference was observed in FBS 
and PPBS of male and female individuals, in case of lipid parameters 
women population showed a significantly (p<0.01) increased risk 
of hypercholesterolemia (11.19%) than men (6.85%), but due to 
comparatively higher value of HDL they showed lower C/H and L/H 
ratio than men. The prevalence of hypertriglyceridemia was more 
among men (29.18%) than in women (20.15%). In general, the 
prevalence of borderline hyperglycemia, hypercholesterolemia, and 
hypertriglyceridemia was higher in studied population (p<0.001, 
p<0.001, and p<0.01, respectively). The higher percent of individuals 
had a greater risk of cardiac problems as indicated by higher C/H and 
L/H ratio (38.26% and 25.96%) among all subjects. Of course, in the 
same variables men showed significantly (p<0.01) higher risk (44.94% 
and 29.24%) than women (26.74% and 19.37%).
In descriptive statistical analysis, a great difference was found in 
minimum and maximum values of different variables. Higher levels 
of 25, 50 (median) and 75 percentiles have been noticed in all, male 
and female populations (Table 3). In one-way ANOVA, a significant 
difference was found in TC (p<0.05), HDL (p<0.0001), VLDL and CRR 
(p<0.001 for both), and TGL (p<0.01). In Student’s t-test, no significant 
difference was found in the mean values of FBS and PPBS across two 
sexes. However, the TCHO and HDL levels were significantly high 
(p<0.05 and p<0.0001, respectively) in women than in men, whereas 
reverse observations were made in case of C/H (p<0.0001), L/H 
(p<0.001), and TGL (p<0.01) in the same populations. A narrow range 
of confidence interval and coefficient of variations indicates that our 
data are consistent with a Gaussian distribution.
DISCUSSION
The present analysis revealed that a higher number of individuals 
showed higher values of blood glucose and different lipid parameters, 
but these were not consistent in all three tested parameters that 
resulted in comparatively less prevalence of metabolic abnormalities 
in general population of Indore. However, the percent and extent of 
abnormality in different parameters were different in individuals 
of different sex and age groups. Since no earlier study has been 
documented in this central Indian population, these results can be 
compared with other studies conducted in different regions of India. 
Earlier studies demonstrated a much higher prevalence of MS in 
urban population of Jaipur (22-25.1%) [4], in urban city dwellers in 
Odisha (24.9% and 42.3%) [10], in Warangal region of Andhra Pradesh 
(54.8% and 45.2%) [22], and in Gwalior-Chambal region of Central 
India (45.8%) [5]. However, the increased values of FBS and PPBS 
in studied population corroborate with the results of Gupta et al. [4] 
where 15.5% male and 10.8% female population were found to be 
diabetic, respectively. Moreover, recently in different studies a higher 
incidence of diabetes was reported from Delhi (15%), Jaipur (20.1%), 
Channai (15.5%), and Kochi (19.5%) [4,23]. Epidemiological studies 
from Kerala, Mumbai, Kolkata, Hyderabad, Guwahati, etc. also indicated 
a higher prevalence of hyperglycemia in common people [24,25]. The 
occurrence of hypercholesterolemia and hypertriglyceridemia was 
also found to be more in the sample population. These data were 
also consistent with the analysis of Durgawale et al. [17] and Sanyal 
et al. [26]. An increased mean values of TCHO, LDL, TGL, C/H and 
L/H with a significant difference was found in different subgroups of 
male and female populations, indicating different degrees of risk for 
cardiovascular disease (CVD) in them [13,17,25].
Table 2: Clinical characteristic of the sample population lies
Groups total Population type FBS PPBS TCHO HDL LDL VLDL C/H L/H TGL
In normal range All 75.96 68.61 66.52 81.63 36.91 68.32 28.73 13.39 68.32
Male 75.27 68.42 69.16 75.11 36.83 66.16 22.53 10.94 66.16
Female 77.22 68.95 61.77 93.41 37.06 72.20 39.92 17.83 72.20
At border line All 5.11 13.92 25.06 10.49 55.09 17.08 33.42 60.63 17.08
Male 5.37 15.13 23.98 14.59 55.88 16.06 33.26 59.87 16.06
Female 4.63 11.69 27.03 3.10 53.66 18.92 33.72 62.01 18.92
At risk/diseased All 18.92 17.47 8.40 7.87 7.98 14.60 37.84 25.96 14.60
Male 19.35 16.44 6.85 10.30 7.28 17.77 44.21 29.18 17.77
Female 18.14 19.35 11.19 3.48 9.26 8.88 26.35 20.15 8.88
Data expressing % of individuals as compare to reference values of given parameters in all, male and female population. FBS: Fasting blood glucose, PPBS: Postprandial 
blood glucose; TCHO: Total cholesterol, HDL: High density lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density lipoprotein, C/H: Ratio of TCHO and HDL, 
L/H: Ratio of LDL and HDL, TGL: Triglyceride
Table 1: Characteristics reference values of different parameters (values are in mg/dl)
Group FBS PPBS TCHO HDL LDL VLDL C/H L/H TGL
Normal <110 <140 <200 >40 <100 2-30 <3.4 <1.5 <150
Border line 111-120 141-180 201-240 30-40 100-160 31-40 3.4-4.5 1.5-3.2 150-200
Risk >120 <180 >240 <30 >160 >40 >4.5 >3.2 >200
The ranges of different parameters are as per NCEP [6]. FBS: Fasting blood glucose, PPBS: Postprandial blood glucose; TCHO: Total cholesterol, HDL: High density 
lipoprotein, LDL: Low density lipoprotein, VLDL: Very low density lipoprotein, C/H: Ratio of TCHO and HDL, L/H: Ratio of LDL and HDL, TGL: Triglyceride
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In our analysis, as compared to males, female population showed 
decreased level of serum TGL and VLDL, as also found in Maharastrian 
and Bengali (Kolkata) population [25]. According to a study of Jhala 
et al. [16], the values of TCHO, TGL, LDL, and VLDL were found to 
be increased with age as also observed in our population. These 
abnormal metabolic factors were also reported to be positively 
correlated with increased rates of non-alcoholic fatty liver disease 
in obese patients [27]. On the other hand, enhanced values of C/H 
and L/H indicated an increased possibility of CVD and ischemic heart 
disease [28] was prominent in males [25].
Collectively various factors determine the progress of these metabolic 
complications including increasing consumption of sweetened 
beverages and high-fat diet that may result in abnormally high serum 
lipid level, overproduction or lack of clearance of these lipoprotein 
particles, or due to other defects in the apolipoproteins or metabolic 
enzyme deficiencies leading to dyslipidemia [2,29,30]. Furthermore, the 
increased serum levels of TG and LDL have been found to be associated 
with increased plasma TNFα and altered levels of adiponectin, 
resistin, leptin, and plasminogen activator inhibitor 1 that may lead 
to insulin resistance by enhancing the production of inflammatory 
cytokines [9,19]. In addition, elevated serum TC and TG are also found 
to induce pancreatitis [31,32] resulting in diabetes.
Thus, the increased prevalence of these MS among common people 
appear to be responsible for progressing diabetes, CVD, hypertension, 
and coronary artery diseases [17,25]. It has also been realized that the 
number of adults with diabetes and CVDs in the world is increasing 
rapidly [30]. Unfortunately, in this study also men and women of 35-
54 years age group showed significantly increased values of FBS, PPBS, 
TCHO, LDL and TGL than reference values.
Our data favored the prediction of Sawant et al. [3], who estimated that 
the CVD will be the major cause of disability and death in India. These 
data suggest a strong need for awareness programs for prevention and 
control of MS [7,18]. There is a need of bringing about dietary changes 
and identifying individuals at high risk of these MS and then taking 
intensive intervention efforts [2,11,23,33,34]. These attempts can serve 
as effective ways to reduce/prevent the incidence of MS and the ever 
increasing burden of diabetes and CVD in general population.
CONCLUSION
In conclusion, this study revealed that the prevalence of MS is 
comparatively less in studied populations, but a greater number of 
individuals have hyperglycemia, hyperlipidemia and increased values 
of cardiac risk factors, indicated that the individuals have a higher 
possibility of cardiac problems. In addition to this, these abnormalities 
were also found to worsen with age. Although this study was conducted 
involving a limited number of human samples, this appears to be the 
first report demonstrating statistically significant alterations in public 
health status. This is further suggested that the people should be made 
aware to improve their routine life.
ACKNOWLEDGMENT
Financial support from University Grant Commission, New Delhi, India 
to Jyoti Agrawal (NET - JRF, Ref. no. 2120930513/20-12-2009 EU IV) 
and staff members of Pathology Department, Bombay Hospital, Indore, 
for data collection are gratefully acknowledged.
REFERENCES
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of 
diabetes: Estimates for the year 2000 and projections for 2030. Diabetes 
Care 2004;27(5):1047-53.
2. Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. 
Nutrients 2013;5(7):2708-33.
3. Sawant A, Mankeshwar R, Shah S, Raghavan R, Dhongde G, Raje H, 
et al. Prevalence of metabolic syndrome in urban India. Cholesterol 
2011;2011:920983.
4. Gupta R, Sharma KK, Gupta A, Agrawal A, Mohan I, Gupta VP, et al. 
Persistent high prevalence of cardiovascular risk factors in the urban 
middle class in India: Jaipur heart watch-5. J Assoc Physicians India 
2012;60:11-6.
5. Yadav D, Mahajan S, Subramanian SK, Bisen PS, Chung CH, Prasad GB. 
Prevalence of metabolic syndrome in Type 2 diabetes mellitus using 
NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior 
Chambal region of Central India. Glob J Health Sci 2013;5(6):142-55.
6. Pandit K, Goswami S, Ghosh S, Mukhopadhyay P, Chowdhury S. 
Metabolic syndrome in South Asians. Indian J Endocrinol Metab 
2012;16(1):44-55.
7. Babu KP, Murthy AG, Girish B, Hamsaveena, Mounika K, Vaishnavi B. 
Metabolic Syndrome among Urban and rural women population - A 
cross sectional study. J Clin Diagn Res 2013;7:1938-40.
8. Siddiqi SS, Misbahuddin, Ahmad F, Rahman SZ, Khan AU. 
Dyslipidemic drugs in metabolic syndrome. Indian J Endocrinol Metab 
2013;17(3):472-9.
9. Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, 
et al. Association of sedentary behaviour with metabolic syndrome: A 
meta-analysis. PLoS One 2012;7(4):e34916.
10. Prasad DS, Kabir Z, Dash AK, Das BC. Prevalence and risk factors for 
metabolic syndrome in Asian Indians: A community study from urban 
Eastern India. J Cardiovasc Dis Res 2012;3(3):204-11.
11. Sadikot SM, Singh V. Managing diabetes in India: Paradigms in 
care - Outcomes and analysis in a comprehensive, clinical practice survey 
of Indian physicians. J Indian Med Assoc 2011;109(11):839-42, 844-8.
12. Prabhakaran D, Singh K. Premature coronary heart disease risk factors 
and reducing the CHD burden in India. Indian J Med Res 2011;134:8-9.
13. Goswami K, Bandyopadhyay A. Lipid profile in middle class Bengali 
Table 3: Descriptive statistics of serum parameters of all sample population, males and female
Variables Gender FBS PPBS TCHO HDL LDL VLDL C/H L/H TGL
Min/Max Male 56/342 65.5/573 69/363 12/127 25.6/239 7.6/265.6 1.54/12.08 0.382/7.91 38/1328


























































Mean±SEM Male 108.7±1.77 140.3±3.38 183.3±1.84 43.38±0.58c 111.2±1.6 28.74±0.85 4.49±0.06a 2.74±0.05 148.0±4.92
Female 108.2±2.55 144.1±4.81 190.2±2.33a 51.67±1.04c, z 114.1±2.05 24.69±0.87a, y 3.97±0.08b, z 2.41±0.06b, z 123.4±4.35a, z
95% CI Male 105.2-112.2 133.6-146.9 179.7-186.9 42.24-44.53 108.1-114.4 27.06-30.43 4.36-4.62 2.64-2.84 138.4-157.7
Female 103.2-113.2 134.6-153.5 185.6-194.8 49.61-53.74 110.1-118.1 22.97-26.4 3.8-4.14 2.29-2.52 114.9-132
CV (%) Male 35.19 51.55 21.68 29.08 31.07 64.42 32.26 40.19 71.91
Female 37.94 52.54 19.75 32.58 28.89 56.73 35.39 41.73 56.73
Min: Minimum value, Max: Maximum value; 25, 50, 75 per: Pertile values at 25%, 50%, 75% level, Mean±SEM: Mean±standard error of mean, CI: Lower to upper 
confidence interval of mean, CV: Coefficient of variation. ap<0.05, bp<0.01 and cp<0.001 as compare to all sample population, yp<0.01 and zp<0.001 as compare to male, 
FBS: Fasting blood glucose, PPBS: Postprandial blood glucose; TCHO: Total cholesterol, HDL: High density lipoprotein, LDL: Low density lipoprotein, VLDL: Very low 
density lipoprotein, C/H: Ratio of TCHO and HDL, L/H: Ratio of LDL and HDL, TGL: Triglyceride
 Agrawal et al.
                                                                                                                                                                Innovare Journal of Medical Science, Vol 5, Issue 1,  2017, 25-28
27
population of Kolkata. Indian J Clin Biochem 2003;18(2):127-30.
14. Estari M, Reddy AS, Bikshapathi T, Satyanarayana J, Venkanna L, 
Reddy MK. Serum lipids and prevalence of dyslipidemia in urban 
adult population of Warangal district, Andhra Pradesh, India. Biol Med 
2009;1:61-5.
15. Mohan V, Radhika G, Vijayalakshmi P, Sudha V. Can the diabetes/
cardiovascular disease epidemic in India be explained, at least 
in part, by excess refined grain (rice) intake? Indian J Med Res 
2010;131:369-72.
16. Jhala CI, Shah UV, Shah TK, Naik BK, Dafda JD. A study of serum 
lipid profile Part-1: Establishment of normal reference values of serum 
lipid levels in healthy vegetarian population of Gujarat. Indian J Clin 
Biochem 1998;13(1):1-7.
17. Durgawale P, Patil S, Shukla PS, Sontakke A, Kakade S, Yadav S. 
Evaluation of reference intervals of serum lipid profile from 
healthy population in Western Maharashtra. Indian J Clin Biochem 
2009;24(1):30-5.
18. Bajaj S, Jawad F, Islam N, Mahtab H, Bhattarai J, Shrestha D, et al. South 
Asian women with diabetes: Psychosocial challenges and management: 
Consensus statement. Indian J Endocrinol Metab 2013;17(4):548-62.
19. Tiwari S; Sadashiv, Paul BN, Kumar S, Chandra A, Dhananjai S, 
Negi MP. TNF-a gene expression in subcutaneous adipose tissue 
associated with HOMA in Asian Indian postmenopausal women. Horm 
Metab Res 2014;46(2):94-9.
20. Parmar HS, Kar A. Protective role of Citrus sinensis, Musa paradisiaca, 
and Punica granatum peels against diet-induced atherosclerosis and 
thyroid dysfunctions in rats. Nutr Res 2007;27:710-18.
21. Deepa PR, Varalakshmi P. Protective effects of certoparin sodium, a low 
molecular weight heparin derivative, in experimental atherosclerosis. 
Clin Chim Acta 2004;339(1-2):105-15.
22. Kumar SV, Nagesh A, Leena M, Shravani G, Chandrasekar V. Incidence 
of metabolic syndrome and its characteristics of patients attending a 
diabetic outpatient clinic in a tertiary care hospital. J Nat Sci Biol Med 
2013;4(1):57-62.
23. Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of 
India. Health Admin 2009;22:1-18.
24. Ashavaid TF, Todur SP, Dherai AJ. Health status of Indian 
population - current scenario. J Assoc Physicians India 2004;52:363-9.
25. Das SK, Faruque AS, Chisti MJ, Ahmed S, Mamun AA, Chowdhury AK, 
et al. Nutrition and lipid profile in general population and vegetarian 
individuals living in rural Bangladesh. J Obes Weight Loss Ther 
2012;2:1-5.
26. Sanyal D, Ghosh S, Mukherjee P, Mukherjee S, Chowdhury S. 
Dyslipidemia, metabolic syndrome, and liver enzymes in impaired 
glucose tolerance and new onset untreated, Type 2 diabetes Indian 
subjects. Indian J Endocrinol Metab 2012;16 Suppl 2:S434-5.
27. Saran S, Philip R, Gutch M, Tyagi R, Agroiya P, Gupta KK. Correlation 
between liver fat content with dyslipidemia and Insulin resistance. 
Indian J Endocrinol Metab 2013;17 Suppl 1:S355-7.
28. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as 
an atherogenic index: Correlation with lipoprotein particle size and 
esterification rate in apob-lipoprotein-depleted plasma (FERHDL). 
Clin Biochem 2001;34:583-8.
29. Das M, Saikia M. Estimation of reference interval of lipid profile in 
Assamese population. India J Clin Biochem 2009;24:190-3.
30. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. 
Sugar-sweetened beverages and risk of metabolic syndrome and Type 2 
diabetes: A meta-analysis. Diabetes Care 2010;33(11):2477-83.
31. Rajesh G, Kumar H, Menon S, Balakrishnan V. Pancreatitis in the setting 
of the metabolic syndrome. Indian J Gastroenterol 2012;31(2):79-82.
32. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: Mechanisms 
and potential targets. Nutrients 2013;5(4):1218-40.
33. Chopra SM, Misra A, Gulati S, Gupta R. Overweight, obesity and 
related non-communicable diseases in Asian Indian girls and women. 
Eur J Clin Nutr 2013;67(7):688-96.
34. Enas EA. Dyslipidemia in the Asian Indian population: Unique aspects 
and implications for treatment. American Association of Physicians of 
Indian Origin; 2002. p. 1-10.
 Agrawal et al. 
                                                                                                                                                                 Innovare Journal of Medical Science, Vol 5, Issue 1, 2017, 25-28
28
